Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-12

Clinical Trial Update: Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of flupenthixol and haloperidol for cocaine-related disorders and other substance-related disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flupenthixol (flupenthixol)
  • HALOPERIDOL (HALOPERIDOL LACTATE)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders, Substance-Related Disorders | Phase 2 | Status: COMPLETED